Last updated: October 21, 2025
Sponsor: Duke University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Congenital Heart Disease
Heart Disease
Pentalogy Of Cantrell
Treatment
Ventripoint Echocardiogram
Transthoracic Echocardiogram or Cardiac MRI
Clinical Study ID
NCT05262907
Pro00108548
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- All patients with functional single ventricles will be included, regardless of ageor surgical palliation stage, who have had or are having a clinically orderedtransthoracic echocardiogram and/or cardiac MRI.
Exclusion
Exclusion Criteria:
- Patients with congenital heart disease other than functional single ventricles,patients with single ventricle physiology (but not single ventricle anatomy)following a biventricular conversion pathway, or patients unable to understand orconsent in English will be excluded.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Ventripoint Echocardiogram
Phase:
Study Start date:
July 08, 2022
Estimated Completion Date:
August 31, 2027
Study Description
Connect with a study center
Duke University
Durham, North Carolina 27705
United StatesSite Not Available
Duke University
Durham 4464368, North Carolina 4482348 27705
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.